Stahler, A., Heinemann, V., Giessen‐Jung, C., Crispin, A., Schalhorn, A., Stintzing, S., Fischer von Weikersthal, L., Vehling‐Kaiser, U., Stauch, M., Quietzsch, D., Held, S., von Einem, J., Holch, J., Neumann, J., Kirchner, T., Jung, A., & Modest, D. (n.d.). influence of mRNA expression of epiregulin and amphiregulin on outcome of patients with metastatic colorectal cancer treated with 5‐FU/LV plus irinotecan or irinotecan plus oxaliplatin as first‐line treatment (FIRE 1‐trial). International journal of cancer, 138(3), 739–746. http://access.bl.uk/ark:/81055/vdc_100027707429.0x00005b